VITEK
Device
bioMerieux
Total Payments
$581,158
Transactions
41
Doctors
2
Companies
1
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2018 | $282,782 | 19 | 0 |
| 2017 | $298,375 | 22 | 2 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $576,115 | 36 | 99.1% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $3,000 | 3 | 0.5% |
| Honoraria | $1,500 | 1 | 0.3% |
| Travel and Lodging | $542.30 | 1 | 0.1% |
Payments by Type
Research
$576,115
36 transactions
General
$5,042
5 transactions
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| VITEK 2 GP19 | bioMerieux | $144,452 | 0 |
| VITEK 2 GN21 | bioMerieux | $87,965 | 0 |
| VITEK2 GP20 | bioMerieux | $69,017 | 0 |
| VITEK2 GN21 | bioMerieux | $59,500 | 0 |
| VITEK2 AF04 | bioMerieux | $50,387 | 0 |
| VITEK2 GN23 | bioMerieux | $35,549 | 0 |
| VITEK 2 AF04 | bioMerieux | $30,311 | 0 |
| VITEK 2 M23 | bioMerieux | $30,205 | 0 |
| VITEK GP20 | bioMerieux | $29,096 | 0 |
| VITEK DensiCHEK | bioMerieux | $19,753 | 0 |
| VITEK2 GN22 | bioMerieux | $18,557 | 0 |
| V2104 Wellcard | bioMerieux | $924.00 | 0 |
| Comparison of MALDI-TOF MS systems for the identification of Mycobacteria and Nocardia | bioMerieux | $400.00 | 0 |
Ad
Manufacturing Companies
- bioMerieux $581,158
Product Information
- Type Device
- Total Payments $581,158
- Total Doctors 2
- Transactions 41
About VITEK
VITEK is a device associated with $581,158 in payments to 2 healthcare providers, recorded across 41 transactions in the CMS Open Payments database. The primary manufacturer is bioMerieux.
Payment data is available from 2017 to 2018. In 2018, $282,782 was paid across 19 transactions to 0 doctors.
The most common payment nature for VITEK is "Unspecified" ($576,115, 99.1% of total).
VITEK is associated with 13 research studies, including "VITEK 2 GP19" ($144,452).